The purpose of this study was to conduct a pilot investigation of the cost-utility of lung transplantation.
With this study we provide a threshold analysis to estimate the survival gains that must be achieved for lung transplantation to be considered a beneficial use of society's resources.
A cross-sectional cohort design was used.
All patients having undergone lung transplantation at the University of Pittsburgh Medical Center between March 1 and August 31,1994, were identified via roster of transplant recipients (n=20).
Surviving patients were interviewed, by telephone, at their 1-year anniversary date.
Utility was assessed by use of the quality of well-being scale.
Direct cost of care was estimated from adjusted charges for the surgical admission, plus physician fees per the Medicare Physician Fee Schedule.
The mean quality of well-being score for this group was 0.54 ± 0.198 SD (median=0.599, range 0 to 0.728).
Summing the physician cost and the adjusted charges for the inpatient operative admission, the average cost of lung transplantation was $153,921 ± $133,981 SD (median $94,324, range $63,405 to $598,482).
At a cost of $94,324 and a utility of 0.599, the survival gain from surgery must be 2.7 years for the cost of the procedure to be justified from a societal perspective.
Because of the many limitations in this pilot study, no firm policy implication may be drawn from these data. (...)
Mots-clés Pascal : Coût, Poumon, Economie santé, Pronostic, Homotransplantation, Survie, Chirurgie, Homme
Mots-clés Pascal anglais : Costs, Lung, Health economy, Prognosis, Homotransplantation, Survival, Surgery, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0044139
Code Inist : 002B25D. Création : 14/05/1998.